GSK Can't Escape Classen's Patent Infringement Suit

Law360, New York (May 30, 2012, 8:42 PM EDT) -- A Maryland federal judge on Tuesday refused to dismiss the bulk of a case against GlaxoSmithKline PLC alleging the pharmaceutical giant infringed Classen Immunotherapies Inc.'s patents for evaluating a vaccine immunization schedule, while tossing contributory and willful infringement claims.

U.S. District Judge William D. Quarles Jr. tossed two infringement claims in a suit accusing GSK of violating patents protecting a method of choosing an immunization schedule for infants that lowers the chance of developing chronic immune-mediated disorders or common infectious diseases.

Although Judge Quarles left Classen...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.